Neuroendocrine gastric carcinoma expressing somatostatin: A highly malignant, rare tumor

World Journal of Gastroenterology

Volumn 12, Issue 24, 2006, Pages 3944-3947

  Waisberg, Jacques ^a,b   de Matos, Leandro Luongo ^a   do Amaral Antonio Mader, Ana Maria ^a   Pezzolo, Sérgio ^a   Eher, Esmeralda Miristene ^c   Capelozzi, Vera Luiza ^c   Speranzini, Manlio Basilio ^a  

^a FACULDADE DE MEDICINA DO ABC   (Brazil)

^b Faculty of Medicine of ABC ^*  (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Carcinoid; Enterochromaffin like cells; Immunohistochemistry; Neuroendocrine carcinoma; Neuroendocrine tumors; Somatostatin; Stomach neoplasms; Tumor markers

Indexed keywords

SOMATOSTATIN;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; DEATH; GASTRECTOMY; GASTROINTESTINAL ENDOSCOPY; HEPATOMEGALY; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; LIVER METASTASIS; MALE; NEUROENDOCRINE TUMOR; PANCREAS RESECTION; POSTOPERATIVE PERIOD; PROTEIN EXPRESSION; REOPERATION; STOMACH BIOPSY; STOMACH CARCINOMA;

EID: 33745852772     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i24.3944     Document Type: Article

References (27)

1. Rindi G, Luinetti O, Cornaggia M, Capella C, Solcia E. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology 1993; 104: 994-1006
2. Matsui K, Jin XM, Kitagawa M, Miwa A. Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants. Arch Pathol Lab Med 1998; 122: 1010-1017
3. Yu JY, Wang LP, Meng YH, Hu M, Wang JL, Bordi C. Classification of gastric neuroendocrine tumors and its clinicopathologic significance. World J Gastroenterol 1998; 4: 158-161
4. Rindi G. Clinicopathologic aspects of gastric neuroendocrine tumors. Am J Surg Pathol 1995; 19 Suppl 1: S20-S29
5. Kloppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci 2004; 1014: 13-27
6. Han HS, Kim HS, Woo DK, Kim WH, Kim YI. Loss of heterozygosity in gastric neuroendocrine tumor. Anticancer Res 2000; 20: 2849-2854
7. Hosoya Y, Nagai H, Koinuma K, Yasuda Y, Kaneko Y, Saito K. A case of aggressive neuroendocrine carcinoma of the stomach. Gastric Cancer 2003; 6: 55-59
8. Staren ED, Lott S, Saavedra VM, Jansson DS, Deziel DJ, Saclarides TJ, Manderino GL, Gould VE. Neuroendocrine carcinomas of the stomach: a clinicopathologic evaluation. Surgery 1992; 112: 1039-1046
9. Rindi G, Bordi C, Rappel S, La Rosa S, Stolte M, Solcia E. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg 1996; 20: 168-172
10. Xie SD, Wang LB, Song XY, Pan T. Minute gastric carcinoid tumor with regional lymph node metastasis: a case report and review of literature. World J Gastroenterol 2004; 10: 2461-2463
11. Solcia E, Rindi G, Fiocca R, Villani L, Buffa R, Ambrosiani L, Capella C. Distinct patterns of chronic gastritis associated with carcinoid and cancer and their role in tumorigenesis. Yale J Biol Med 1992; 65: 793-804
12. Helpap B, Kollermann J. Immunohistochemical analysis of the proliferative activity of neuroendocrine tumors from various organs: Are there indications for a neuroendocrine tumor-carcinoma sequence? Virchows Arch 2001; 438: 86-91
13. Qvigstad G, Qvigstad T, Westre B, Sandvik AK, Brenna E, Waldum HL. Neuroendocrine differentiation in gastric adenocarcinomas associated with severe hypergastrinemia and/or pernicious anemia. APMIS 2002; 110: 132-139
14. Chejfec G, Kovarick P, Graham G, Eichorst M, Gould VE. Neuroendocrine carcinoma of the stomach with extensive somatostatin immunoreactivity. Ultrastrutural Pathol 1992; 16: 537-545
15. Solcia E, Capella C, Vassallo G, Buffa R. Endocrine cells of the gastric mucosa. Int Rev Cytol 1975; 42: 223-286
16. Saito H, Saito S. Plasma somatostatin in normal subjects and in various diseases: increased levels in somatostatin-producing tumors. Horm Metab Res 1982; 14: 71-76
17. Bonar SF, Sweeney EC. The prevalence, prognostic significance and hormonal content of endocrine cells in gastric cancer. Histopathology 1986; 10: 53-63
18. Bordi C, Ravazzola M. Endocrine cells in the intestinal metaplasia of gastric mucosa. Am J Pathol 1979; 96: 391-398
19. Mendelsohn G, de la Monte S, Dunn JL, Yardley JH. Gastric carcinoid tumors, endocrine cell hyperplasia, and associated intestinal metaplasia. Histologic, histochemical, and immunohistochemical findings. Cancer 1987; 60: 1022-1031
20. Waldum HL, Brenna E, Sandvik AK. Relationship of ECL cells and gastric neoplasia. Yale J Biol Med 1998; 71: 325-335
21. Solcia. E, Rindi G, Larosa S, Capella C. Morphological, molecular, and prognostic aspects of gastric endocrine tumors. Microsc Res Tech 2000; 48: 339-348
22. Makhlouf HR, Burke AP, Sobin LH. Carcinoid tumors of the ampulla of Vater: a comparison with duodenal carcinoid tumors. Cancer 1999; 85: 1241-1249
23. Kaizaki Y, Fujii T, Kawai T, Saito K, Kurihara K, Fukayama M. Gastric neuroendocrine carcinoma associated with chronic atrophic gastritis type A. J Gastroenterol 1997; 32: 643-649
24. Solcia E, Rindi G, Paolotti D, Luinetti O, Klersy C, Zangrandi A, La Rosa S, Capella C. Natural history, clinicopathologic classification and prognosis of gastric ECL cell tumors. Yale J Biol Med 1998; 71: 285-290
25. Otsuji E, Yamaguchi T, Taniguchi H, Sakakura C, Kishimoto M, Urata Y, Tsuchihashi Y, Ashihara T, Takahashi T, Yamagishi H. Malignant endocrine carcinoma of the stomach. Hepatogastroenterology 2000; 47: 601-604
26. Moertel CG, Kvols LK, O'Connell MJ, Rubin J. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer 1991; 68: 227-232
27. Fukui H, Takada M, Chiba T, Kashiwagi R, Sakane M, Tabata F, Kuroda Y, Ueda Y, Kawamata H, Imura J, Fujimori T. Concurrent occurrence of gastric adenocarcinoma and duodenal neuroendocrine cell carcinoma: a composite tumour or collision tumours? Gut 2001; 48: 853-856